Cargando…

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy

Detalles Bibliográficos
Autores principales:	Yi, Jia-Qin, Huang, Sheng, Wu, Miao-Juan, Ma, Jie-Hui, Huang, Li-Juan, Liang, Song, Sun, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571130/ https://www.ncbi.nlm.nih.gov/pubmed/37841932 http://dx.doi.org/10.3389/fphar.2023.1295784

Ejemplares similares

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
por: Zhao, Fen, et al.
Publicado: (2023)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Comparison of Lamotrigine and Oxcarbazepine Monotherapy Among Chinese Adult Patients With Newly-Diagnosed Focal-Onset Epilepsy: A Prospective Observational Study
por: Chen, Yuncan, et al.
Publicado: (2022)

EEG-Driven Prediction Model of Oxcarbazepine Treatment Outcomes in Patients With Newly-Diagnosed Focal Epilepsy
por: Wang, Bin, et al.
Publicado: (2022)

Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open‐label, randomized study
por: Zhu, Haoyue, et al.
Publicado: (2022)

Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
por: Zhao, Binyang, et al.
Publicado: (2022)

Efficacy and safety of perampanel monotherapy in patients with focal‐onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open‐label Study 342 (FREEDOM Study)
por: Yamamoto, Takamichi, et al.
Publicado: (2020)

Effect of Oxcarbazepine on Language Function in Patients With Newly Diagnosed Pediatric Epilepsy
por: Han, Min Jeong, et al.
Publicado: (2023)

Effectiveness of perampanel in the treatment of pediatric patients with focal epilepsy and ESES: A single-center retrospective study
por: Yu, Tao, et al.
Publicado: (2022)

Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
por: Saxena, S., et al.
Publicado: (2021)

Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023)

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)

Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
por: Liu, Wan-Ting, et al.
Publicado: (2020)

Perampanel for focal epilepsy: insights from early clinical experience
por: Trinka, E., et al.
Publicado: (2015)

Evaluation of perampanel as monotherapy for focal seizures: Experience from open-label extension studies
por: Kwan, Patrick, et al.
Publicado: (2017)

Long‐term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open‐label extension study
por: Trinka, Eugen, et al.
Publicado: (2020)

Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021)

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open‐label Study 342 (FREEDOM)
por: Husni, Ryan Edbert, et al.
Publicado: (2021)

Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
por: Li, Dan, et al.
Publicado: (2022)

Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
por: Silva, Rui, et al.
Publicado: (2023)

Glymphatic system function in patients with newly diagnosed focal epilepsy
por: Lee, Dong Ah, et al.
Publicado: (2022)

Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019)

Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up
por: Kim, Soo Yeon, et al.
Publicado: (2018)

Time-to-Seizure Modeling of Lacosamide Used in Monotherapy in Patients with Newly Diagnosed Epilepsy
por: Lindauer, Andreas, et al.
Publicado: (2017)

Effectiveness and safety of Lacosamide therapy for children with focal epilepsy: a real world study
por: Yang, Chunsong, et al.
Publicado: (2023)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Impact of diagnostic delay on seizure outcome in newly diagnosed focal epilepsy
por: Parviainen, Laura, et al.
Publicado: (2020)

Efficacy and safety of perampanel monotherapy in Chinese patients with focal‐onset seizures: A single‐center, prospective, real‐world observational study
por: Ma, Haiyan, et al.
Publicado: (2023)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017)

Perampanel and Visuospatial Skills in Children With Epilepsy
por: Operto, Francesca Felicia, et al.
Publicado: (2021)

Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy
por: Ben‐Menachem, Elinor, et al.
Publicado: (2019)

The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis
por: Yue, Xuan, et al.
Publicado: (2023)

Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients
por: Seo, Jong-Geun, et al.
Publicado: (2007)

Effect of Oxcarbazepine on Background EEG Activity and Cognition in Epilepsy
por: Kim, Sung Min, et al.
Publicado: (2013)

Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
por: Berghuis, Bianca, et al.
Publicado: (2021)

Patient-Reported Outcome Measures in Adult Patients Diagnosed with Epilepsy Being Treated with Perampanel
por: Moseley, Brian D, et al.
Publicado: (2022)

A retrospective, real‐world experience of perampanel monotherapy in patient with first new onset focal seizure: A Thailand experience
por: Chinvarun, Yotin
Publicado: (2021)

Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study
por: Liguori, Claudio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_41jr3i7q8936nb7b64mocau637